Giovanni Cacciamani, MD

Associate Professor of Research Urology

Image of Giovanni Cacciamani, MD
Is this your profile? Click to edit

Overview

Dr Giovanni Cacciamani is a urologist and surgeon-scientist, recognized internationally for his contributions to oncological diseases, patient safety, and the integration of artificial intelligence (AI) into healthcare. He is an Associate Professor of Urology and Radiology Research at the University of Southern California (USC), USA and serves as the Director of the Artificial Intelligence Center for Surgical and Clinical Applications in Urology with cutting-edge research initiatives at the intersection of urology, technology, and clinical innovation.

Dr Cacciamani is also actively involved in shaping the future of AI and digital health in urology on a global scale. He chairs the Young Academic Urologists (YAU) UroTechnology and Digital Healthcare Group of the European Association of Urology (EAU), a role through which he promotes technological advancements and digital transformation in the field of Urology. He serves as Associate Editor for the Journal of Urology, for the section on Innovation and AI.

His dedication to healthcare innovation has been widely recognized. In 2022, he was honored as Citizen of the Year (Italy) for his pioneering work in medical technology, and he received the Italian Matula Award, the most prestigious recognition for the best Italian urologist under 40.

Dr Cacciamani has authored about 400 scientific publications (H-Index 43 – Scopus 05/2026) and has delivered over 250 lectures worldwide on emerging technologies, AI, and digital medicine applications in urology. His lab at USC is currently exploring the potential of Generative AI (GAI) in healthcare, focusing on making AI more accessible and practical for practicing physicians. With a deep commitment to bridging technology and clinical practice, Dr Cacciamani goal is conducting innovative research and education efforts, shaping the future of AI-driven urology and digital healthcare worldwide.

Publications

  • Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng’s Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53.. View in PubMed
  • Reporting standards for the use of large language model-linked chatbots for health advice. Nat Med. 2023 Dec; 29(12):2988.. View in PubMed
  • The Impact of Telemedicine in Reducing the Carbon Footprint in Health Care: A Systematic Review and Cumulative Analysis of 68 Million Clinical Consultations. Eur Urol Focus. 2023 11; 9(6):873-887.. View in PubMed
  • Giovanni E. Cacciamani, MD, MSc, FEBU. J Urol. 2024 02; 211(2):326-327.. View in PubMed
  • Criteria for enhancing reporting of perioperative transfusions in surgical and anaesthesiological studies. Br J Surg. 2023 11 09; 110(12):1655-1658.. View in PubMed
  • Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024 02; 85(2):146-153.. View in PubMed
  • Quality of information and appropriateness of ChatGPT outputs for urology patients. Prostate Cancer Prostatic Dis. 2024 Mar; 27(1):159-160.. View in PubMed
  • Patients’ Trust in Artificial Intelligence-based Decision-making for Localized Prostate Cancer: Results from a Prospective Trial. Eur Urol Focus. 2024 Jul; 10(4):654-661.. View in PubMed
  • Can the Abdominal Aortic Atherosclerotic Plaque Index Predict Functional Outcomes after Robot-Assisted Partial Nephrectomy? Diagnostics (Basel). 2023 Oct 27; 13(21). Veccia A, Serafin E, Tafuri A, Mal . View in PubMed
  • Impact of persistent PSA after salvage radical prostatectomy: a multicenter study. Prostate Cancer Prostatic Dis. 2024 Dec; 27(4):686-692.. View in PubMed